Kevin Joseph Fitzgerald, CSO & EVP, Head of Research: Alnylam Pharmaceuticals ALNY Sell · Filed 02/17

Trade details

Type: Insider sale
Amount: $677,530.36
Shares · price: 2,041 sh · $331.96 a share
Held after: 21,264 sh
Stock: Alnylam Pharmaceuticals ALNY
Person: Kevin Joseph FitzgeraldCSO & EVP, Head of Research
Trade date: 26/02/17
Filed: 26/02/17
Days to filing: 0 days

Sold 8.8% of holdings

Share of holding sold: 8.8%

Alnylam Pharmaceuticals trades, last 26 weeks

What else happened in Alnylam Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 01/18~03/19

Kevin Joseph Fitzgerald's recent trades

Kevin Joseph FitzgeraldCSO & EVP, Head of Research
Sell10b5-1 planAlnylam Pharmaceuticals
Sell10b5-1 plan
Alnylam Pharmaceuticals
ALNY
$75.3K
233 sh
$75.3K
Filed 03/06
Traded 03/05
Kevin Joseph FitzgeraldCSO & EVP, Head of Research
Sell10b5-1 planAlnylam Pharmaceuticals
Sell10b5-1 plan
Alnylam Pharmaceuticals
ALNY
$68K
210 sh
$68K
Filed 03/06
Traded 03/04
Kevin Joseph FitzgeraldCSO & EVP, Head of Research
Sell10b5-1 planAlnylam Pharmaceuticals
Sell10b5-1 plan
Alnylam Pharmaceuticals
ALNY
$49.9K
153 sh
$49.9K
Filed 03/06
Traded 03/05
Kevin Joseph FitzgeraldCSO & EVP, Head of Research
Sell10b5-1 planAlnylam Pharmaceuticals
Sell10b5-1 plan
Alnylam Pharmaceuticals
ALNY
$48K
148 sh
$48K
Filed 03/06
Traded 03/05
Kevin Joseph FitzgeraldCSO & EVP, Head of Research
Sell10b5-1 planAlnylam Pharmaceuticals
Sell10b5-1 plan
Alnylam Pharmaceuticals
ALNY
$39.9K
124 sh
$39.9K
Filed 03/06
Traded 03/05

Kevin Joseph Fitzgerald, EVP — sold $677.5K of Alnylam Pharmaceuticals ALNY · 8.8% of holdings · 10b5-1 plan | Whalegun